Immunoscintigraphy with anti-chromogranin A antibodies inpatients with endocrine/neuroendocrine tumors
- 1 November 1993
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 16 (10) , 841-843
- https://doi.org/10.1007/bf03348939
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.Journal of Clinical Endocrinology & Metabolism, 1993
- 99mTc Labeled Biotin Conjugate in a Tumor “Pretargeting” Approach with Monoclonal AntibodiesAngewandte Chemie International Edition in English, 1992
- Chromogranin B (secretogranin I), a secretory protein of the regulated pathway, is also present in a tightly membrane-associated form in PC12 cells.Journal of Biological Chemistry, 1992
- Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.1991
- Chromogranin A and B in Adenomas of the PituitaryThe American Journal of Surgical Pathology, 1991
- Chromogranin A: Its Role in Endocrine Function and as an Endocrine and Neuroendocrine Tumor Marker*Endocrine Reviews, 1991
- Monoclonal antibody pretargetting techniques for tumour localizationNuclear Medicine Communications, 1991
- Synaptophysin and chromogranins/secretogranins widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosisVirchows Archiv B Cell Pathology Including Molecular Pathology, 1989
- Preparation and characterization of anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodiesMolecular and Cellular Probes, 1989
- Chromogranin, an integral membrane protein.Journal of Biological Chemistry, 1985